AbCellera Biologics Inc. (ABCL) › Shareholders' EquityAbCellera Biologics Inc. (ABCL) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: $11.61M2019: $10.25M2020: $830.51M2021: $1.03B2022: $1.23B2023: $1.15B2024: $1.06B2025: $966.90M$966.90M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$966.90M-8.4%2024$1.06B-8.4%2023$1.15B-6.6%2022$1.23B+20.2%2021$1.03B+23.5%2020$830.51M+8000.9%2019$10.25M-11.7%2018$11.61M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share